Acadia Pharmaceuticals Inc. is rated a Buy for its steady NUPLAZID/DAYBUE franchises & pipeline-driven upside potential. Read more on ACAD stock here.
The US Court of Appeals for the Federal Circuit affirmed attorneys’ fees awards against EscapeX IP, LLC, finding the case “exceptional” under ...
Below, CNBC Select explains the differences between trademarks, copyrights and patents. Read on for more information and to ...
Zacks Investment Research on MSN
Can Merck's new products aid growth as Keytruda LOE test looms?
Merck MRK is going to face a major patent cliff, as its blockbuster PD-L1 therapy Keytruda is nearing loss of exclusivity ...
Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug ...
Council and Parliament reach provisional deal on a set of rules for new genomic techniques, aiming to improve the ...
ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the ...
Introduction - Far too often, startup founders treat intellectual property (IP)—especially patents—like an item on a to-do list.
The U.S. International Trade Commission (ITC) found the violation of one patent owned by Infineon Technologies AG (FSE: IFX) (OTCQX: IFNNY) concerning gallium nitride (GaN) technology by Innoscience.
South Korean company’s Doosan Bobcat's North American unit has filed patent infringement lawsuits against Caterpillar (CAT) ...
Infineon Technologies said the U.S. International Trade Commission ruled in its favor in a patent case against Chinese company Innoscience. The German chip maker said the commission preliminarily ...
Innoscience said at midday on December 3 via the Hong Kong Stock Exchange that it had prevailed in its US patent dispute with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback